Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.

1988 • 214 citations

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.

1995 • 210 citations

Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer

1993 • 183 citations

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.

1986 • 172 citations

Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial

1990 • 119 citations

Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.

1985 • 112 citations

Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes

1992 • 109 citations

Breast conservation treatment of early stage breast cancer: patterns of failure

1995 • 106 citations

Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): III. The Significance of Extranodal Extension of Axillary Metastases

1976 • 104 citations

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole

1987 • 103 citations

Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings.

1992 • 102 citations

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.

1990 • 100 citations

Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors

1993 • 98 citations

Prognostic Significance of Axillary Nodal Status in Primary Breast Cancer in Relation to the Number of Resected Nodes

1992 • 96 citations

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1983 • 76 citations

Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: Evaluation of the role of postoperative radiotherapy

1989 • 74 citations

Microscopic extracapsular extension in the axilla: Is this an indication for axillary radiotherapy?

1995 • 72 citations

Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure

1989 • 72 citations

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1994 • 65 citations

A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.

1990 • 50 citations

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes

1989 • 35 citations

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results

1989 • 27 citations

Prognosis in breast cancer patients with tumour cells in the efferent vessels of their axillary nodes

1983 • 22 citations

The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation

1992 • 19 citations

Low-Risk Breast Cancer Patients Treated by Mastectomy and Lower Axillary Dissection: The present status of the Danish Breast Cancer Cooperative Group Trial 77-A

1988 • 10 citations

West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.

1992 • 9 citations